Impact of an Antiretroviral Stewardship Team on the Care of Patients With Human Immunodeficiency Virus Infection Admitted to an Academic Medical Center.

HIV antiretroviral stewardship

Journal

Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 06 06 2019
accepted: 17 06 2019
entrez: 25 7 2019
pubmed: 25 7 2019
medline: 25 7 2019
Statut: epublish

Résumé

Interdisciplinary antiretroviral stewardship teams, comprising a human immunodeficiency virus pharmacist specialist, an infectious diseases physician, and associated learners, have the ability to assist in identification and correction of inpatient antiretroviral-related errors. Electronic medical records of patients with antiretroviral orders admitted to our hospital were evaluated for the number of interventions made by the stewardship team, number of admissions with errors identified, risk factors for occurrence of errors, and cost savings. Risk factors were analyzed by means of multivariable logistic regression. Cost savings were estimated by the documentation system Clinical Measures. A total of 567 admissions were included for analysis in a 1-year study period. Forty-three percent of admissions (245 of 567) had ≥1 intervention, with 336 interventions in total. The following were identified as risk factors for error: multitablet inpatient regimen (odds ratio, 1.834; 95% confidence interval, 1.160-2.899; Antiretroviral stewardship teams optimize patient care through identification and correction of antiretroviral-related errors. Errors may be more common in patients with multitablet inpatient regimens, admission to the intensive care unit, care provided by a surgery service, and increased number of hospital days reviewed. Once antiretroviral-related errors are identified, the ability to correct them provides cost savings.

Sections du résumé

BACKGROUND BACKGROUND
Interdisciplinary antiretroviral stewardship teams, comprising a human immunodeficiency virus pharmacist specialist, an infectious diseases physician, and associated learners, have the ability to assist in identification and correction of inpatient antiretroviral-related errors.
METHODS METHODS
Electronic medical records of patients with antiretroviral orders admitted to our hospital were evaluated for the number of interventions made by the stewardship team, number of admissions with errors identified, risk factors for occurrence of errors, and cost savings. Risk factors were analyzed by means of multivariable logistic regression. Cost savings were estimated by the documentation system Clinical Measures.
RESULTS RESULTS
A total of 567 admissions were included for analysis in a 1-year study period. Forty-three percent of admissions (245 of 567) had ≥1 intervention, with 336 interventions in total. The following were identified as risk factors for error: multitablet inpatient regimen (odds ratio, 1.834; 95% confidence interval, 1.160-2.899;
CONCLUSIONS CONCLUSIONS
Antiretroviral stewardship teams optimize patient care through identification and correction of antiretroviral-related errors. Errors may be more common in patients with multitablet inpatient regimens, admission to the intensive care unit, care provided by a surgery service, and increased number of hospital days reviewed. Once antiretroviral-related errors are identified, the ability to correct them provides cost savings.

Identifiants

pubmed: 31338383
doi: 10.1093/ofid/ofz290
pii: ofz290
pmc: PMC6639729
doi:

Types de publication

Journal Article

Langues

eng

Pagination

ofz290

Références

Infect Control Hosp Epidemiol. 2014 Mar;35(3):272-7
pubmed: 24521593
Pharm Pract (Granada). 2015 Jan-Mar;13(1):512
pubmed: 25883687
Am J Health Syst Pharm. 2007 Oct 1;64(19):2064-8
pubmed: 17893418
Clin Infect Dis. 2012 Aug;55(4):593-9
pubmed: 22610923
Am J Health Syst Pharm. 2012 Mar 1;69(5):422-30
pubmed: 22345421
Ann Pharmacother. 2013 Jul-Aug;47(7-8):953-60
pubmed: 23737513
Pharmacotherapy. 2016 Mar;36(3):245-51
pubmed: 26833760
Infect Control Hosp Epidemiol. 2012 Apr;33(4):322-7
pubmed: 22418625
P T. 2015 May;40(5):353-60
pubmed: 25987824
HIV Med. 2011 Sep;12(8):494-9
pubmed: 21395966
J Int Assoc Provid AIDS Care. 2016 Jan-Feb;15(1):84-8
pubmed: 26289342
Antivir Ther. 2015;20(5):555-9
pubmed: 25560773
J Pharm Technol. 2014 Apr;30(2):48-53
pubmed: 34860871
Ann Pharmacother. 2008 Apr;42(4):491-7
pubmed: 18349307
Am J Health Syst Pharm. 2000 Dec 15;57(24):2283-4
pubmed: 11146973
J Antimicrob Chemother. 2014 Jan;69(1):262-7
pubmed: 23956374
Clin Infect Dis. 2006 Oct 1;43(7):933-8
pubmed: 16941379
Am J Health Syst Pharm. 2018 Jun 15;75(12):876-885
pubmed: 29720459
Ann Pharmacother. 2014 May 8;48(8):998-1010
pubmed: 24811394
Ann Pharmacother. 2000 Jul-Aug;34(7-8):833-8
pubmed: 10928390

Auteurs

Ashley M DePuy (AM)

Department of Pharmacy Services, Temple University Hospital, Philadelphia, Pennsylvania.

Rafik Samuel (R)

Section of Infectious Diseases, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania.

Kerry M Mohrien (KM)

Department of Pharmacy Services, Temple University Hospital, Philadelphia, Pennsylvania.

Elijah B Clayton (EB)

Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania.

David E Koren (DE)

Department of Pharmacy Services, Temple University Hospital, Philadelphia, Pennsylvania.

Classifications MeSH